Accellacare

Accellacare, ICON's global clinical research network, incorporating PMG Research (US) and MeDiNova (EMEA) site networks, provides greater access to patients and multi-specialty physicians for our customers. This network of research sites, offers proven, professional clinical research resources and infrastructure for your clinical research.

Increased patient access
Accellacare unlocks access to millions of patients, streamlines the clinical trial process, and delivers an unprecedented model of predictability and standardisation in clinical research. 

Quicker start-up
Experienced, regulatory, contracts and start-up staff support the site to be activated more quickly and streamlined standardised processes for trial conduct result in successful enrollment and delivery of high quality data.

Quality and compliant services
Consistent, centralised training programs in quality assurance and compliance ensures that we are inspection ready. Centralised SOPs and Core Operating Guidelines (COGs) as well as oversight and a focus on quality results in positive outcomes.

Site and patient burden assessment for protocol optimisation
Accellacare direct access to Investigators to review study operations and resolve standard of care questions and connection to patients to query procedure burden and patient centric approaches. We will review with you the features of the study protocol, exploring the risks and how these might impact patient enrollment. Time and motion analysis enables us to review the burden level of the trial on the investigative site and the patient. This together with industry data collated from multiple studies, across a wide spectrum of therapeutic areas and indications, helps us to identify the potential risks of delays in recruitment and enables us to develop a site and patient solution that meets the challenges of your specific study.

Clinical research as a care option for patients

Patient Voice

Managed by Accellacare, the Patient Voice programme enables us to leverage the patient perspective for feasibility, recruitment and retention. This research and insight, based on information from patient surveys, forums and focus groups, also supports our patient recruitment and retention team and therapeutic specialists as they identify the key milestones in the patient journey.

By leveraging this information we are able to develop protocol-specific support solutions and patient engagement strategies resulting in a more holistic, patient-centric approach. Using the patient profile and the treatment pathway to further define who the patient is, we create a customised recruitment and retention strategy for the entire study.